What is MedLeap?

The greatest advantage of KBIC is that the city itself—not just isolated research facilities or hospitals—serves as a comprehensive testing and validation ground.

With research centers, hospitals, and corporations co-located in the same area, ideas born in the lab can immediately transition to validation and clinical phases.
The ability to seamlessly design the entire workflow—from Proof of Concept (PoC) and pilot testing to clinical trials and social implementation—provides a immense advantage for medical startups.

Furthermore, the close proximity allows for daily discussions with physicians and researchers, accelerating development and enhancing validation accuracy. We provide a city-scale environment designed to move beyond theoretical studies—testing, refining, and advancing solutions directly in the field.

The supercomputer Fugaku, successor to the K computer, is housed at the RIKEN Center for Computational Science on Port Island and continues to demonstrate world-class performance in the latest global rankings.

It is utilized across various fields such as drug discovery and disaster prevention, and contributed significantly to COVID-19 countermeasures through advanced viral droplet simulations.

For medical startups to achieve sustainable growth, they must be designed for global expansion from day one, rather than focusing solely on the domestic market.

At KBIC, startups can access a world-class development and validation environment through international joint research and partnerships with overseas institutions.
With accumulated expertise tailored to international clinical trials and global regulatory compliance, outcomes achieved in domestic validations can smoothly bridge into the next target markets.

Additionally, an environment gathering multinational researchers and corporations naturally cultivates the perspective needed to refine products to global standards. The technology and track record built here will serve as a solid foundation for the next stage of growth.